My apologies, ARGS does use the total tumor RNA according to the Investor Day video and the ESMO update. However, the Poster Session – Immunotherapy, from Wednesday 29 November 2016, seems to indicate they use RNA from only 100mg of tumor tissue, though it does say process adjustments were used for larger amounts. I just wanted to clarify that as I'm not someone who spreads misinformation knowingly.. I make a lot of mistakes as a beginner investor so my posts are for entertainment and discussion only. Unfortunately, no one corrected me here.
